Atherosclerosis News

New research from Rockefeller University now shows that when chronically activated, the protein rejiggers how cholesterol is broken down in and cleared from the liver, a disturbance that can lead to high levels of the waxy substance or worse, full-blown atherosclerosis.

Dr. Thomas Behrenbeck is a native of Germany, where he received his medical education at the Westfalian Wilhelm University in Munster and became board certified in internal medicine and cardiology.

Main Category: Statins Also Included In: Cholesterol ; Clinical Trials / Drug Trials Article Date: 23 Oct 2009 - 2:00 PDT printer friendly view / write opinions rate article New Phase III data published in "Current Medical Research and Opinion" highlight that the recommended starting dose of 2 mg of LIVALO , a novel synthetic statin, was ...

New Phase III data published today in "Current Medical Research and Opinion" highlight that the recommended starting dose of 2 mg of LIVALO , a novel synthetic statin, was statistically superior to simvastatin at a dose of 20 mg over 12 weeks in reducing low-density lipoprotein cholesterol , non-high-density lipoprotein cholesterol and total ...

Treatments for atherosclerosis range from changing your lifestyle, to medications and then to more aggressive treatments such as angioplasty.

Belgian drug discovery company Galapagos NV Wednesday said it has expanded its drug alliance with Merck & Co.

For the past several months I've been taking a remarkable nutritional supplement that: - Lowers my triglyceride levels and helps keep me trim and lean; - Decreases my risk of developing coronary artery disease and dying suddenly because of a heart arrhythmia; - Alleviates my joint pain and helps keep my mood mellow; - Prompts my wife to sometimes ...

Daiichi Sankyo, Inc. announced today that the U.S. Food and Drug Administration has approved the supplemental new drug application for WelcholA to be used as an adjunct to diet and exercise for the reduction of elevated low-density lipoprotein cholesterol in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial ...

U. of I. emeritus veterinary biosciences professor Fred Kummerow, who is 94, has spent nearly six decades studying lipid biochemistry, and has petitioned the FDA for a ban on trans fats in food.

Dr. Mann is assistant professor of medicine, Mount Sinai School of Medicine, New York, New York.

New data presented showed that in patients treated with LIVALO , high-density lipoprotein cholesterol concentrations increased, and nearly three-fourths of patients attained low-density lipoprotein cholesterol targets, with results sustained over 52 weeks.

Dear Dr. Gott: A friend of mine recently underwent chelation. It has something to do with filtering the blood in your system.

TSX Exchange Symbol: RVX Additional quarterly and clinical updates included CALGARY, Aug.

Growing New Coronary Arteries Scientists continue to experiment successfully with the use of stem cells to engineer regeneration: "researchers have identified stem cells that are able to grow new coronary arteries , a finding that could lead to new ways to treat atherosclerosis .

U.S. researchers have identified stem cells that are able to grow new coronary arteries, a finding that could lead to new ways to treat atherosclerosis .

Low density lipoprotein is known as bad cholesterol . If too much LDL builds up in your body, it can cause blockage known as plaque to form and harden and can narrow your arteries.

Q: I had an executive check up last week and all my results are normal except for my cholesterol which at 280 mg/dL was high.

Pediatric asthma patients at Advocate Hope Children's Hospital can breathe easier thanks to new treatment guidelines from the National Heart, Lung, and Blood Institute's Expert Panel Report.

DRUG NEWS TYPE 2 DIABETES Fenofibrate reduces odds for amputation In a large study of patients with type 2 diabetes, fenofibrate lowered the risk of first amputation and minor amputation in people without known large-vessel disease.

Mississippi will receive $100,000 as part of a settlement with with Merck & Co. Inc, Shering-Plough Corporation, and a joint venture of the two companies, MSP Singapore Company, LLC, Attorney General Jim Hood said.